Users of this format don't need to install excessive plugins or software to attempt the Salesforce Certified Agentforce Life Sciences Consultant (ALS-Con-201) web-based practice exams. Another format of the Salesforce Certified Agentforce Life Sciences Consultant (ALS-Con-201) practice test is the desktop-based software. This ALS-Con-201 Exam simulation software needs installation only on Windows computers to operate. The third format of the Prep4cram Salesforce ALS-Con-201 exam dumps is the ALS-Con-201 Dumps PDF.
| Certification Vendor: | Salesforce |
|---|---|
| Exam Name: | Salesforce Certified Agentforce Life Sciences Consultant |
| Exam Number: | ALS-Con-201 |
| Available Languages: | English |
| Exam Duration: | 105 minutes |
| Certificate Validity Period: | 2 years |
| Real Exam Qty: | 60-65 |
| Passing Score: | 62% |
| Exam Format: | Multiple-choice, Scenario-based |
| Exam Price: | US$200 |
| Related Certifications: | Salesforce Certified Platform Administrator |
| Recommended Training: | Agentforce Life Sciences Consultant Certification Preparation |
| Exam Registration: | Salesforce Certification Registration |
| Sample Questions: | Salesforce ALS-Con-201 Sample Questions |
| Exam Way: | Online proctored or onsite testing center |
| Pre Condition: | Hold Salesforce Certified Platform Administrator certification; at least 1 year experience in life sciences industry; at least 6 months hands-on experience configuring Agentforce Life Sciences |
| Official Syllabus URL: | https://help.salesforce.com/s/articleView?id=005305357&language=en_US |
>> ALS-Con-201 Latest Dumps Ppt <<
As we all know, if you want to pass the ALS-Con-201 exam, you need to have the right method of study, plenty of preparation time, and targeted test materials. However, most people do not have one or all of these. That is why I want to introduce our ALS-Con-201 Original Questions to you. So why not try our Salesforce original questions, which will help you maximize your pass rate? Even if you unfortunately fail to pass the exam, we will give you a full refund.
| Topic | Details |
|---|---|
| Topic 1 |
|
| Topic 2 |
|
| Topic 3 |
|
| Topic 4 |
|
NEW QUESTION # 88
Choose 1 option.
When sending email using the Agentforce Life Sciences mobile app, who can field sales reps CC on the message?
Answer: C
Explanation:
The correct answer is A because Salesforce Life Sciences Field Email allows field users to add colleagues as CC recipients. Salesforce Help for customizing and sending emails in Life Sciences Cloud states that users can send emails to healthcare professionals and healthcare organizations from their workflow, select an email template, and add colleagues as CC recipients.
This distinction matters for compliance. In Life Sciences engagement, HCPs and HCOs are the intended external recipients of approved email communications. The CC field is not intended as a free-form way to add additional HCPs. Instead, CC is used for internal collaboration or visibility, such as copying a colleague involved in the account, territory, or follow-up process. This helps keep HCP communications controlled, trackable, and aligned with approved email workflows.
Option B is incorrect because it suggests both HCPs and colleagues can be CC'd. Although emails are sent to HCPs or HCOs, Salesforce's documented CC behavior specifically references colleagues as CC recipients. Option C is also incorrect because HCPs are the primary external recipients, not the users who should be copied in the CC field. Therefore, when sending email from the Agentforce Life Sciences mobile app, field sales reps can CC colleagues.
=========
NEW QUESTION # 89
Choose 1 option.
A field sales rep attempts to add Immunexis to the Product Detailing section during a visit, but the product does not appear in the search results. The product record exists in Salesforce. The product must be explicitly enabled for use in visit discussions.
What should be configured in the Visit Administration tile on the Agentforce Life Sciences for Customer Engagement Admin Console?
Answer: A
Explanation:
The correct answer is B because the product must be enabled for discussion in the visit-detailing experience. Salesforce's Life Sciences Visit Management developer documentation states that information entered in a provider visit typically includes product details, product messages, presentations, marketing items, and samples. Salesforce Trailhead also explains that Life Sciences Cloud uses product administration and product-message configuration to ensure reps only promote and discuss therapies within approved guardrails.
The scenario says the product exists in Salesforce, but it does not appear when the rep tries to add it to the Product Detailing section during a visit. That means the issue is not product creation; it is visit-discussion eligibility. The consultant should configure Product Discussion Settings in the Visit Administration area so Immunexis is available for product detailing and visit discussions.
Option A is incorrect because Territory Product Alignment Rules determine which products are aligned to territories, but the question specifically says the product must be explicitly enabled for use in visit discussions. Territory alignment alone does not guarantee the product appears in the Product Detailing search. Option C is also incorrect because Visit Record Type Mappings control record-type behavior, not whether a product can be discussed. Therefore, the correct configuration is Product Discussion Settings.
NEW QUESTION # 90
Choose 1 option.
Cumulus Pharma wants to launch a new product, "Immunexis," and mandates that field sales reps must capture explicit opt-in consent from Healthcare Providers (HCPs) before sending any digital marketing materials. The following records are already configured in Agentforce Life Sciences:
Data Use Purpose record for "Immunexis Marketing"
Communication Subscription record named "Immunexis KOL Webinar Series"
Engagement Channel Type record for "Email"
When reps attempt to capture consent on their iPads, they can see the "Immunexis KOL Webinar Series" subscription, but they cannot select "Email" as a channel to capture the opt-in preference.
Which step resolves this issue so the rep can select "Email" for this subscription?
Answer: A
Explanation:
Option B is correct because Communication Subscription Channel Type is the junction record that links a Communication Subscription to an Engagement Channel Type. Salesforce's Life Sciences Consent Management data model includes Communication Subscription, Communication Subscription Channel Type, Communication Subscription Consent, Data Use Purpose, Engagement Channel Type, and related consent objects. This confirms that subscription-channel availability is modeled through Communication Subscription Channel Type, not only through the subscription or channel records separately.
Salesforce's Communication Subscription objects documentation states that Communication Subscription Channel Type specifies the engagement channel that can be used to contact the customer for a communication subscription. The Salesforce object reference also identifies fields on Communication Subscription Channel Type such as EngagementChannelTypeId, confirming that this object connects the subscription to the channel.
Option A is incorrect because there is no indication that a generic "Allow Email Channel" checkbox controls this relationship. Option C is also incorrect because Communication Subscription Consent stores an individual HCP's consent preference after the channel-subscription combination exists. It does not make the Email channel selectable for the subscription. Therefore, the consultant must create a Communication Subscription Channel Type record linking "Immunexis KOL Webinar Series" to the Email Engagement Channel Type.
NEW QUESTION # 91
Choose 1 option.
Cumulus Pharma wants to customize the provider summary to include additional information stored in Agentforce Life Sciences for Customer Engagement. An Agentforce Life Sciences Consultant updated the Actionable Relationship Center (ARC) graph used in provider summarization to include additional objects and fields.
How should the consultant ensure that Provider Summary Generation uses the new information to meet business goals?
Answer: A
Explanation:
The correct answer is A because provider summary generation depends on the prompt template and the data supplied to that prompt. In Life Sciences Cloud account summarization, Salesforce documentation references custom prompt templates for account summarization and the account summarization workflow, while the workflow uses the Generate Provider Account Territory Summary flow as part of the summary-generation process. Salesforce also documents that this flow calls actions such as Get Object Relationship Data and Get Life Sciences Configuration Field Names, meaning the flow participates in retrieving relationship-based data, but the generated business summary still needs the prompt template to know what information to use and how to summarize it.
Updating the ARC graph alone makes additional objects and fields available in the relationship structure, but it does not automatically change the prompt's summarization behavior. To ensure the new information is used correctly, the consultant should create a new prompt template version, update the input dataset so the new fields are included, revise the summarization instructions so the AI knows how to use them, and then activate that version. This aligns with Salesforce's guidance that prompt-based generation relies on the configured prompt and its grounding/input data. Option B is incomplete because changing only the flow does not update the prompt's instructions. Option C is also incorrect because batch-job configuration controls bulk execution, not the actual summarization logic.
NEW QUESTION # 92
Choose 1 option.
An Agentforce Life Sciences Consultant at Cumulus Pharma created a new field set on the Account object to display specific custom fields in the Agentforce Life Sciences mobile app. The consultant successfully navigated to the Admin Console, updated the Account Lists configuration to reference this new field set, and saved the settings.
However, when a field sales rep logs in to the app, the new fields are not visible in the Account List columns; the app continues to display the old layout.
Which action will push these Admin Console configuration changes to the app?
Answer: C
Explanation:
The correct answer is B because Life Sciences mobile app configuration changes must be synchronized to the mobile experience through metadata cache generation. Salesforce Help states that configuration changes are synced to the Life Sciences Cloud mobile app by generating a metadata cache, and that the generated metadata cache includes object schemas and related metadata required by the mobile app. Salesforce also states that a new metadata cache should be generated when administrators update Lightning record pages, page layouts, object or schema changes, new or modified feature settings, or related mobile configuration.
In this case, the consultant correctly updated the Account Lists configuration in the Admin Console to use a new Account field set. The reason the app still shows the old Account List layout is that the mobile app has not received the updated metadata. Running the Mobile Metadata Cache update pushes the refreshed configuration to the app so that field sales reps can see the new Account List columns.
Option A is incorrect because the issue is not with the Account Lightning record page. The change was made to Account Lists in the Admin Console, not to the record page layout. Option C is also incorrect because deleting and reinstalling the app is a user-side workaround and does not publish new admin metadata. The proper administrator action is to run the metadata cache update.
=========
NEW QUESTION # 93
......
Pdf ALS-Con-201 Version: https://www.prep4cram.com/ALS-Con-201_exam-questions.html